Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$58.3K
20.48K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 20.48K shares of EDITAS MEDICINE, INC. valued at approximately $58.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2026ACC: 0001650664-26-000087
DirectorOfficer· CEO
Since Jun 2022
20.48K
Shares to sell
$58.3K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
9/2/2026
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2026 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
15.38K
Market value
$41.5K
6/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.10K
Market value
$16.7K
9/3/2026
Total
Units
20.48K
Value
$58.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/3/2026 | 15.38K | $41.5K | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 5.10K | $16.7K | NASDAQ | Planned |
| Total | 20.48K | $58.3K | ||